相关实验视频

Updated: Jun 11, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

467

RNA技术和纳米载体赋予 in vivo 嵌合式抗原受体疗法的权力

Jingsheng Cai1,2,3, Shaoyi Chen1,2,3, Zheng Liu1,2,3

  • 1Thoracic Oncology Institute, Peking University People's Hospital, Beijing, People's Republic of China.

Immunology
|September 28, 2024
PubMed
概括

使者RNA (mRNA) 疫苗的成功刺激了纳米医学在RNA技术和体内仿真抗原受体 (CAR) 治疗方面的进步. 本综述探讨了基于RNA的CAR结构和用于改进癌症治疗的交付.

关键词:
这是一个RNARNARNARNARNA.在体内进行CAR疗法.纳米载体的纳米载体

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

11.6K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.4K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489